Trials / Terminated
TerminatedNCT02921646
Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer
Monocentric, Prospective Study Assessing the Feasibility to Use Resting Energy Expenditure by Indirect Calorimetry as Prognostic Marker of Tumoral Response to 1st Line Chemotherapy in Patients Suffering From Metastatic Pancreatic Cancer
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Center Eugene Marquis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether evolution of resting energetic expenditure is a predictive marker of tumoral response for patients suffering from metastatic pancreatic cancer and treated with 1st line of chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Measure of resting energetic expenditure | measure of resting energetic expenditure |
Timeline
- Start date
- 2017-07-10
- Primary completion
- 2019-07-10
- Completion
- 2019-07-10
- First posted
- 2016-10-03
- Last updated
- 2020-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02921646. Inclusion in this directory is not an endorsement.